NMDA Receptor Blockade at Rest Triggers Rapid Behavioural Antidepressant Responses
Nature June 15, 2011 Anita E. Autry, M. Adachi, E. Nosyreva et al.
Clinical studies consistently demonstrate that a single sub-psychomimetic dose of ketamine, an ionotropic glutamatergic NMDAR (N-methyl-D-aspartate receptor) antagonist, produces fast-acting antidepressant responses in patients suffering from major depressive disorder, although the underlying mechanism is unclear. Depressed patients report the alleviation of major depressive disorder symptoms...